Levin Capital Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-17,399
| Closed | -$485K | – | 345 |
|
|
2017
Q2 | $485K | Sell |
17,399
-4,513
| -21% | -$126K | 0.01% | 199 |
|
|
2017
Q1 | $753K | Buy |
+21,912
| New | +$753K | 0.01% | 169 |
|
|
2016
Q4 | – | Sell |
-12,000
| Closed | -$382 | – | 304 |
|
|
2016
Q3 | $382 | Buy |
+12,000
| New | +$382 | 0.01% | 250 |
|
|
2016
Q2 | – | Sell |
-7,904
| Closed | -$221K | – | 337 |
|
|
2016
Q1 | $221K | Buy |
+7,904
| New | +$221K | ﹤0.01% | 299 |
|
|
2015
Q3 | – | Sell |
-5,000
| Closed | -$209K | – | 365 |
|
|
2015
Q2 | $209K | Sell |
5,000
-20,000
| -80% | -$836K | ﹤0.01% | 354 |
|
|
2015
Q1 | $815K | Buy |
+25,000
| New | +$815K | 0.01% | 234 |
|